Latest Kaiser Health News Stories
Even as it chips away at Obamacare, the Trump administration is solidly behind state-based initiatives to cover high-cost patients, known as “reinsurance” programs. It approved two more last month.
Many insurers added surcharges to policies they sold to individuals last year to make up for a cut in federal funding. Now, federal officials suggest that states encourage insurers to sell policies without those surcharges outside of the marketplace to help people who don’t get a premium subsidy.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
The moves could lead to a dramatic decrease in hospitals and doctors participating in the program, industry officials said.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about the latest Trump administration efforts to address high drug prices, what’s next for short-term health insurance plans and insider trading charges against a New York GOP congressman.
Young physicians are pushing the medical establishment to rethink its long-held opposition. The political fallout could be substantial.
The number of diabetes drug prescriptions filled for low-income people enrolled in Medicaid rose sharply in states that expanded eligibility for the program under the Affordable Care Act, according to a new study.
Under the Trump administration’s new rule, these plans can now last as long as 12 months — instead of the Obama-era 90-day limit — and be renewed for two additional years. Critics say these changes are part of another swipe at the Affordable Care Act.
Many of the GOP-led states seeking to overturn the Affordable Care Act could end up jeopardizing the health of their own residents, who suffer from preexisting conditions at rates higher than the national average. The ACA requires insurers to cover people with histories of illness and not charge them more for it. If the law is overturned, that protection could be lost, as California Healthline reporter Harriet Rowan explains on “The VICE Guide to Right Now” podcast.
The administration says these plans, which can now last as long as 12 months and be renewed for two years, will give consumers another less-pricey insurance option. Critics say the new rule is yet another swipe at the Affordable Care Act.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Alice Ollstein of Talking Points Memo and Rebecca Adams of CQ Roll Call talk about health care’s emergence as a possible voting issue in the coming midterm elections. Plus, Rovner interviews KHN’s Emmarie Huetteman about July’s “Bill of the Month”: a transgender woman’s “bait-and-switch” $92,000 surgical bill.
Grants by top pharma group to lightly regulated, politically active nonprofits dwarf its conventional campaign spending.
After a San Francisco speech focused mostly on Medicare, Seema Verma fielded questions that underscored the administration’s differences with California on other key health care issues.
The average increase in California is smaller than the double-digit hikes expected around the nation, due largely to a healthier mix of enrollees and more competition in its marketplace. Still, health insurance prices keep growing faster than wages and general inflation.
A coalition of Republican states has launched a legal challenge to the Affordable Care Act, including provisions requiring insurers to offer coverage to people with preexisting conditions without raising rates. An analysis shows that some of these states have the highest proportion of such residents.
Republicans’ overwhelming majorities in the state legislature make pursuing a policy that could benefit 660,000 uninsured adults a “long shot,” political analysts say.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Julie Appleby of Kaiser Health News discuss the health politics of the latest Supreme Court pick, as well as the Trump administration’s efforts to further undermine the Affordable Care Act. Plus, for extra credit, the panelists recommend their favorite health stories of the week.